Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Queensland Health
Johnson and Johnson
QuintilesIMS
Cantor Fitzgerald
AstraZeneca
US Army
US Department of Justice

Generated: January 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Emricasan

« Back to Dashboard

US Patents for Emricasan

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Emricasan ➤ Try a Free Trial C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Idun Pharmaceuticals, Inc. (La Jolla, CA) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Idun Pharmaceuticals, Inc. (San Diego, CA) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Idun Pharmaceuticals, Inc. (San Diego, CA) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Idun Pharmaceuticals, Inc. (San Diego, CA) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial Caspase inhibitor prodrugs Vertex Pharmaceuticals Incorporated (Cambridge, MA) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial Crystalline forms Pfizer, Inc. (New York, NY) ➤ Try a Free Trial
Emricasan ➤ Try a Free Trial Caspase inhibitors based of pyridazinone scaffold LG Life Sciences Ltd. (Seoul, KR) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Emricasan

Drugname Country Document Number Estimated Expiration Related US Patent
Emricasan Austria 348096 2018-07-02 ➤ Try a Free Trial
Emricasan Austria 442843 2018-07-02 ➤ Try a Free Trial
Emricasan Australia 4856999 2018-07-02 ➤ Try a Free Trial
Emricasan Australia 752339 2018-07-02 ➤ Try a Free Trial
Emricasan Brazil 9911675 2018-07-02 ➤ Try a Free Trial
Emricasan Canada 2336474 2018-07-02 ➤ Try a Free Trial
Emricasan Canada 2433879 2018-07-02 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
QuintilesIMS
Julphar
Teva
UBS
Accenture
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.